Comment on: Butler et al. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? Diabetes Care 2013;36:2118–2125

por Bjerre Knudsen, Lotte, Nyborg, Niels C. Berg, Svendsen, Claus Bo, Vrang, Niels, Moses, Alan C.
Publicado 2013